| Weizmann Institute of Science, Ben-Gurion University of the Negev|Anat Cohen-Dayag Wikipedia
Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli Biotechnology firm Compugen Ltd, a company involved in drug discovery. She had worked as a scientist at the R&D department of Orgenics.
She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science.